Beyond US: New shores, new bets
The US remains a key market for Indian pharma. But changing conditions are pushing India to diversify its global footprint. The…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Indian Pharma Industry
India’s pharma exports rise 6.8% to $8.1 billion in Q1 FY27
Pharmexcil data shows growth across formulations, bulk drugs, vaccines and surgical products, with the US remaining the largest…
Commerce Ministry highlights pharma export growth in Mumbai outreach
Government details 12-year reforms, rising exports, trade partnerships and roadmap for value-led expansion at Pharmexcil event
Quality under pressure: Strengthening continuity amid geopolitical uncertainty
One of the most persistent risks facing Indian pharma manufacturers is the industry's heavy dependence on China for KSMs and…
US tariffs leave Indian pharma unaffected, industry voices relief
Trump’s new tariffs impose 26% duty on India, while pharma remains exempt. Industry experts weigh in on the impact
EY Parthenon – OPPI report claims India’s pharma sector set for rapid growth
The report titled ‘Viksit Bharat@2047: Transforming India from pharmacy of the world to pharma powerhouse for the world’ states…
Regulatory convergence is extremely important
Regulatory convergence is extremely important because the basis of all this is science. Science is an objective thing so it…
DCGI waives off local trials for drugs approved in well-regulated markets
The countries on the list include the US, UK, Japan, Australia, Canada and the EU
Decoding Budget 2024-25: A lacklustre budget for pharma
The Finance Minister announced the Budget for 2024-25 on July 23, during the Monsoon Session of Parliament
Indian pharma industry in 21st century – What has changed for domestic supply?
Dr Ashok Omray, Pharma Consultant, points out that despite significant advancements, the Indian pharma industry grapples with…